Conclusively, high NSE at baseline is associated with poor 1-year AIS outcomes in hypertension patients, especially in patients with NIHSS score less than 3, suggesting that NSE may be a potential prognostic biomarker and therapeutic target for stroke patients with hypertension. The gene discussed is ENO2; the disease is Stroke.